News

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future (Vienna, 05.12.2023) The St. Anna Children’s Cancer Research Institute celebrates 35 years at the forefront of scientific efforts against pediatric cancer. On this anniversary, the institute granted rare insights into its laboratories, showcasing the cutting-edge research that is conducted. Afterwards, the management presented

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future Read More »

CLOSER Leukemia General Assembly: Sabine Strehl presents joint work package

CLOSER Leukemia General Assembly: Sabine Strehl presents joint work package (Vienna, 20.11.2023) Sabine Strehl from St. Anna Childrens Cancer Research Institute, recently participated in the CLOSER Leukemia General Assembly in Santiago de Chile, presenting alongside her colleagues Patricia Rubio and Maria Sara Felice from Garrahan Hospital, Buenos Aires. They shared the latest outcomes from their

CLOSER Leukemia General Assembly: Sabine Strehl presents joint work package Read More »

VULSK Specialists Immerse in Clinical Trials Training at St. Anna CCRI under TREL Project

VULSK Specialists Immerse in Clinical Trials Training at St. Anna CCRI under TREL Project (Vienna, 17.11.2023) The EU-funded project TREL seeks to bridge gaps in research indicators and treatment outcomes by fostering collaboration, knowledge sharing, and skill development. This week, the St. Anna Childrens Cancer Research Institute warmly welcomed three specialists from Vilnius University Hospital Santaros Klinikos (VULSK)

VULSK Specialists Immerse in Clinical Trials Training at St. Anna CCRI under TREL Project Read More »

3rd School of Malignant Lymphomas in Ljubljana

3rd School of Malignant Lymphomas in Ljubljana (Vienna, 19.10.2023) The 3rd School of Malignant Lymphomas in Ljubljana recently concluded its first day, marking a significant milestone in the field of lymphoma research and diagnostics. The event featured contributions from St. Anna CCRI’s  scientists, Margarita Maurer-Granofszky and Anna-Maria Husa, who led insightful workshops focused on high-end

3rd School of Malignant Lymphomas in Ljubljana Read More »

Network-based approaches open a new avenue to classify and treat rare diseases

Network-based approaches open a new avenue to classify and treat rare diseases Scientists at CeMM, Max Perutz Labs, and St. Anna Children’s Cancer Research Institute have achieved a significant advancement in the research of rare immune system disorders. Through a network-based approach, they have reclassified approximately 200 rare diseases. Initial comparisons with clinical data already

Network-based approaches open a new avenue to classify and treat rare diseases Read More »

Gene Mutation in the Immune System: Anti-Diabetes Drugs Make Immune Cells More Effective Again

Gene Mutation in the Immune System: Anti-Diabetes Drugs Make Immune Cells More Effective Again (Vienna, 31.08.2023) T cells are an essential component of the immune system – they fight foreign structures such as bacteria and viruses or cancer-related changes in cells. This defense reaction requires energy. Scientists led by the St. Anna Children’s Cancer Research Institute

Gene Mutation in the Immune System: Anti-Diabetes Drugs Make Immune Cells More Effective Again Read More »

“I think there are few things that so many people agree on as that it is good to support St. Anna CCRI!”

“I think there are few things that so many people agree on as that it is good to support St. Anna CCRI!” (Vienna, 28.08.2023) “Science Buster” and molecular biologist Martin Moder in brief: Why he supports the St. Anna Children’s Cancer Research Institute, how he deals with criticism, and what he currently likes doing best!

“I think there are few things that so many people agree on as that it is good to support St. Anna CCRI!” Read More »

Childhood cancer: “New” immune system responds better to therapy

(Vienna, 9.8.2023) Scientists at St. Anna Children’s Cancer Research Institute and the Eberhard Karls University of Tübingen have shown that immunotherapy after stem cell transplantation effectively combats certain nerve tumors in children. Crucially, stem cells from a parent provide children with a new immune system that responds much better to immunotherapies. These results of an early clinical trial were published in the prestigious Journal of Clinical Oncology.

Childhood cancer: “New” immune system responds better to therapy Read More »

St. Anna CCRI welcomes George Cresswell as new Principal Investigator

St. Anna CCRI welcomes George Cresswell as new Principal Investigator (Vienna, 01.08.2023) British bioinformatician George Cresswell has been studying various forms of childhood cancer, especially nephroblastoma, since his student days. As Principal Investigator at St. Anna Children’s Cancer Research Institute, he will turn his attention to the evolutionary biology of cancer cells in an attempt

St. Anna CCRI welcomes George Cresswell as new Principal Investigator Read More »

Sarcoma Awareness Month: exposing an insidious Nemesis

Sarcoma Awareness Month: exposing an insidious Nemesis (Vienna, 27.07.2023) Sarcomas pose a significant challenge, especially for children and adolescents, as the tumors often go undetected and metastasize. At St. Anna Children’s Cancer Research Institute, two research groups are dedicated to studying this tumor. Sarcomas are rare forms of cancer, comprising only two percent of all

Sarcoma Awareness Month: exposing an insidious Nemesis Read More »